Api-structure (Api Structure)
Dapagliflozin Tablet, Film Coated
Product Images NDC 69097-388
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 69097-388). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label 5mg (Container Label 5mg)
This text appears to be a label for Dapagliflozin tablets. It includes details such as the quantity (30 tablets), manufacturer (Cipla), and expiration date (Rev. 9/2024). Additionally, it mentions that information like serial number, expiry, and lot number will be overprinted during commercial packing.*
Container Label 10mg (Contanier Label 10mg)
Figure-01 (Figure 01)
This is a description of a graph showing the relationship between Dapagiflozin Dose (mg) and 24-Hr Urinary Glucose levels in healthy subjects and subjects with type 2 diabetes (T20M). The x-axis shows the Dapagiflozin dose in mg, while the y-axis represents the 24-Hr Urinary Glucose levels in grams. The graph includes observed values for both healthy subjects and those with T20M, as well as fitted lines for each group.*
Figure-02 (Figure 02)
Figure-03 (Figure 03)
Figure-04 (Figure 04)
Figure-05 (Figure 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
